Document Detail


Switching cholinesterase inhibitors in older adults with dementia.
MedLine Citation:
PMID:  21044399     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
ABSTRACTBackground: Cholinesterase inhibitors (ChEIs) represent the mainstay of symptomatic treatment in Alzheimer's disease. Three medications belonging to this class are presently widely available. These agents differ in their individual mechanisms of action and pharmacokinetic properties. Switching ChEIs can be a reasonable option in cases of intolerance or lack of clinical benefit.Methods: A systematic literature search of switching ChEIs was conducted, and all studies specifically evaluating this issue were identified. Published consensus guidelines were also searched for recommendations on ChEI switching.Results: Eight clinical studies are summarized and discussed. All of these studies are open-label or retrospective and they cannot be readily compared because of heterogeneity in design, number of patients, agents used, and endpoints. Switching in most of these studies was done for both "lack of benefit" or "loss of response" after up to 29 months of treatment. Nevertheless, the majority of studies did not include individuals switched for lack of response after several years of treatment. Lack of satisfactory response or intolerance with the initial agent was not predictive of similar results with the second agent.Conclusions: In light of these findings, we propose the following practical approach to switching ChEIs: (1) in the case of intolerance, switching to a second agent should be done only after the complete resolution of side-effects following discontinuation of the initial agent; (2) in the case of lack of efficacy, switching can be done overnight, with a quicker titration scheme thereafter; (3) switching ChEIs is not recommended in individuals who show loss of benefit several years after initiation of treatment.
Authors:
Fadi Massoud; Julie Eve Desmarais; Serge Gauthier
Related Documents :
18502519 - Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papill...
11256729 - History and evidence-based medicine: lessons from the history of somatic treatments fro...
19588349 - Lidocaine for preventing postoperative sore throat.
10499179 - The natural history of multiple sclerosis: implications for trial design.
11361189 - Work status and its determinants among patients with ankylosing spondylitis. a systemat...
15106239 - Hyperbaric oxygen therapy for chronic wounds.
21692409 - Comparison of local steroid injection into carpal tunnel via proximal and distal approa...
23204069 - Mucociliary transport in porcine trachea: differential effects of inhibiting chloride a...
7878539 - Infrainguinal bypass in patients with end-stage renal disease.
Publication Detail:
Type:  Journal Article     Date:  2010-11-03
Journal Detail:
Title:  International psychogeriatrics / IPA     Volume:  23     ISSN:  1741-203X     ISO Abbreviation:  Int Psychogeriatr     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-02-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007918     Medline TA:  Int Psychogeriatr     Country:  England    
Other Details:
Languages:  eng     Pagination:  372-8     Citation Subset:  IM    
Affiliation:
Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, Service de Gériatrie, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The immunohistochemical examination of GABAergic interneuron markers in the dorsolateral prefrontal ...
Next Document:  Clinical and economic characteristics associated with direct costs of Alzheimer's, frontotemporal an...